BriaCell Therapeutics
(NASDAQ:BCTX)
6.25
-0.23[-3.55%]
At close: Jun 28
6.30
0.0500[0.80%]
After Hours: 7:40PM EDT
Day High/Low6.17 - 6.45
52 Week High/Low4.06 - 12.47
Open / Close6.45 / 6.25
Float / Outstanding- / 15.5M
Vol / Avg.165.5K / 858.9K
Mkt Cap97M
P/E-
50d Avg. Price5.84
Div / Yield-
Payout Ratio-
EPS-0.32
Total Float11.6M

BriaCell Therapeutics (NASDAQ:BCTX), Quotes and News Summary

BriaCell Therapeutics (NASDAQ: BCTX)

Day High/Low6.17 - 6.45
52 Week High/Low4.06 - 12.47
Open / Close6.45 / 6.25
Float / Outstanding- / 15.5M
Vol / Avg.165.5K / 858.9K
Mkt Cap97M
P/E-
50d Avg. Price5.84
Div / Yield-
Payout Ratio-
EPS-0.32
Total Float11.6M
Benzinga - Feb 28, 2022, 8:20AM
Benzinga - Jan 5, 2022, 10:15AM
load more
BriaCell Therapeutics Corp is an immuno-oncology focused biotechnology company developing targeted and safe approaches for the management of cancer. BriaCell, in collaboration with Incyte Corp., is conducting a Phase I/IIa clinical trial of Bria-IMT, its lead candidate, in a Combination Study with Incyte drugs, INCMGA00012, and epacadostat, in advanced breast cancer. Additionally, it is developing Bria-OTS, off-the-shelf personalized immunotherapy, for advanced breast cancer. Bria-OTS immunotherapy treatments are personalized to match the patient without the need for personalized manufacturing and is designed to produce a potent and selective immune response against the cancer of each patient eliminating the time, expense and complex manufacturing logistics associated with immunotherapies.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS-0.320
REV0
Q2 2022Est.ActualSurprise
EPS-0.240
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

BriaCell Therapeutics Questions & Answers

Q
How do I buy BriaCell Therapeutics (BCTX) stock?
A

You can purchase shares of BriaCell Therapeutics (NASDAQ: BCTX) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are BriaCell Therapeutics's (BCTX) competitors?
A

There are no as such competitors for BriaCell Therapeutics.

Q
What is the target price for BriaCell Therapeutics (BCTX) stock?
A

The latest price target for BriaCell Therapeutics (NASDAQ: BCTX) was reported by HC Wainwright & Co. on Monday, February 14, 2022. The analyst firm set a price target for 25.00 expecting BCTX to rise to within 12 months (a possible 300.00% upside). 1 analyst firms have reported ratings in the last year.

Q
Current Stock Price for BriaCell Therapeutics (BCTX)?
A

The stock price for BriaCell Therapeutics (NASDAQ: BCTX) is $6.25 last updated June 28, 2022, 8:00 PM UTC.

Q
Does BriaCell Therapeutics (BCTX) pay a dividend?
A

There are no upcoming dividends for BriaCell Therapeutics.

Q
When is BriaCell Therapeutics (NASDAQ:BCTX) reporting earnings?
A

BriaCell Therapeutics’s Q3 earnings are confirmed for Monday, June 13, 2022.

Q
Is BriaCell Therapeutics (BCTX) going to split?
A

There is no upcoming split for BriaCell Therapeutics.

Q
What sector and industry does BriaCell Therapeutics (BCTX) operate in?
A

BriaCell Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.